The Effects of Offline Anosognosia For Spatial Neglect on Neglect Rehabilitation
Launched by GAZI UNIVERSITY · Nov 23, 2021
Trial Information
Current as of September 01, 2025
Completed
Keywords
ClinConnect Summary
Babinski described the term "anosognosia" in 1914 as a phenomenon characterized by unawareness of the paralysis in patients with right hemisphere lesions. Now, this term is used for not only ignorance of hemiplegia but also unawareness of somatosensory, visual deficits, or cognitive disorders like aphasia and memory problems. Another phenomenon, hemispatial neglect (HN), is inattention and decreased responsiveness to the contralesional half of the space that cannot be attributed to the primary motor and sensory deficits. In this perspective, anosognosia for spatial neglect is an intriguing ...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Being older than 18 years of age
- • Having subacute or chronic right hemisphere injury
- • Having left-sided hemispatial neglect based on Catherine Bergego Scale assessment.
- Exclusion Criteria:
- • Acute cerebral injury (within the first two weeks of disease),
- • Bilateral cerebral lesions
- • Other neurological and psychiatric disorders that prevent evaluation of HN (e.g., severe cognitive or primer visual impairment)
About Gazi University
Gazi University, a leading research institution based in Ankara, Turkey, is committed to advancing medical knowledge and improving patient care through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university integrates cutting-edge research with clinical practice to explore new therapeutic approaches and enhance existing treatments. Gazi University adheres to the highest ethical standards and regulatory guidelines, ensuring the integrity and safety of its clinical trials. By fostering partnerships with healthcare professionals and academic institutions, Gazi University aims to contribute significantly to the global scientific community and address pressing health challenges.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Trial Officials
Gülçin Kaymak Karataş, MD
Principal Investigator
Gazi University Faculty of Medicine
Levent Karataş, MD
Principal Investigator
Gazi University Faculty of Medicine
Ayça Utkan Karasu, MD
Principal Investigator
Gazi University Faculty of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials